MicroRNAs (miRNAs) are endogenous small RNAs (length, 18-23 nucleotides) that regulate gene expression. Recently, plasma miRNAs have been investigated as biomarkers for various diseases. In the present study, we explored cell-or tissue-specific miRNAs and assessed the applicability of miRNA profiling for identifying biomarkers of tissue injuries. miRNA analyses in various human and rat tissues identified several candidate miRNAs with possible tissue-specific expression, some of which have already been reported. In the present study, we focused on pancreas-specific miRNAs, miR-216a and miR-216b. Laser microdissection revealed that miR-216a and 216b were predominantly expressed in acinar cells of the pancreas as compared to Langerhans' islet. Plasma concentrations of miR-216a and miR-216b considerably increased in a rat model of L-arginineinduced acute pancreatitis. The current results have confirmed that miRNA expression profiling in various cells is useful for providing biomarkers for cell-or tissue-specific injuries.
MicroRNAs (miRNAs) are endogenous small RNAs that comprise approximately 18-23 nucleotides and bind to the 3′-untranslated region of messenger RNAs of protein-coding genes to downregulate their expression (2, 7) . miRNAs play an important role in various physiological and pathological processes (12, 27) . So far, more than 1,500 human miRNAs have been identified (http://www.mirbase.org). They are expressed in a tissue-or cell-specific manner (29) . Most human protein-coding genes are thought to be targeted by miRNAs (17, 31 ) that appear to function as rheostats to fine-tune protein output (4, 37) . Recently, miRNAs were reported to be present in various body fluids (11, 12, 20) . More than 90 types of miRNAs have been detected in human sera using the 2nd-generation sequencer, Solexa (11) . Plasma miRNAs are incorporated into RNA-induced silencing complexes as well as into exosomes and/or microparticles (1, 22, 24) . We recently reported that the plasma concentrations of myocardium-specific miRNAs are excellent biomarkers of myocardial infarction (1, 24) and cerebral infarction (43) . We also found that the plasma concentration of miR-126 is negatively correlated with the severity of heart failure (18) and that plasma concentrations of a hypoxiainduced miRNA, miR-210, are increased in patients with congestive heart failure (13) . Other groups also reported that plasma miRNAs are sensitive and specific biomarkers of various tissue injuries and pathological conditions (30, 34, 38, 40) . In the present study, we further tried to discover cell-or tissue-specific miRNAs and strengthened the validity of miRNA profiling as a useful method to identify biomarkers of tissue injuries.
MATERIALS AND METHODS
Total RNAs from tissue samples. Human RNAs from various tissues (brain, cerebellum, lung, adrenal gland, kidney, placenta, liver, heart, uterus, testis, trachea, prostate, colon, thyroid, skeletal muscle, salivary gland, spleen, and pancreas) were obtained from Clontech-TAKARA (CA, USA). Rat tissues and the results should be validated by real-time reverse transcriptase-polymerase chain reaction (RT-PCR) using individual assay kits. Since validity of some of commercially available kits appears to be unreliable, real-time RT-PCR should be conducted with reference samples of known amounts of synthetic miRNA.
Validation of miRNA expression in tissue RNAs. The expression levels of candidate miRNAs were measured using the TaqMan microRNA RT-PCR kit (Applied Biosystems) (10) . The reliability of the individual assay kit was assessed by using known amounts of synthetic miRNA. The 7500 Fast RealTime PCR System (Applied Biosystems) was used for amplification and detection. C T values were obtained from the amplification plot using the SDS software.
Assessment of plasma miRNAs as biomarkers in a rat model of acute pancreatitis. Male SD rats (4 weeks old) were housed in a temperature-controlled room on a 12-h light/12-h dark cycle. They were fed rat chow (Oriental Yeast, Tokyo, Japan) and tap water ad libitum. Acute pancreatitis was induced in SD rats (n = 25, 5 at each time point) by injecting 2 × 250 mg/100 g body weight of L-arginine (Sigma, MO, USA) intraperitoneally at 1-h intervals, as a 20% solution in 0.15 mol/L NaCl (28) . After sampling caval vein blood, the rats were killed at 0, 12, 24, 48, and 72 h after arginine administration. A portion of the pancreatic tissue was fixed in 10% buffered formalin for histological studies. After fixation, tissue was embedded in paraffin and 6 μm sections were cut and stained with hematoxylin-eosin. The sections were examined under a light microscope. Acute pancreatitis was confirmed by elevated plasma amylase levels and typical inflammatory features, which were observed microscopically. The rats were anesthetized with pentobarbital, and blood was drawn from the inferior vena cava and collected into ethylenediaminetetraacetic acid (EDTA)-containing vials for RNA analysis and into heparin-containing vials for amylase measurement; heparin served as the anticoagulant. Plasma was isolated by centrifugation at 1,600 × g for 15 min at 4°C. Plasma RNA was isolated using the mirVana PARIS kit (Ambion). As an internal reference, a known amount of a synthetic artificial miRNA was added to the plasma samples as described previously (1, 13, 18) . Plasma amylase concentrations were measured with an automatic analyzer (DRI-Chem 7000Z; FUJIFILM, Tokyo, Japan).
(brain, cerebellum, heart, kidney, liver, lung, ovary, pancreas, prostate, retina, salivary gland, small intestine, spleen, stomach, testis, and skeletal muscle) were resected from male Sprague-Dawley (SD) rats (4 weeks old). Total RNA was extracted from these tissues with the TRIzol reagent (Invitrogen, CA, USA), as described previously (23, 41, 42) .
Total RNAs from cell samples. The laser microdissection (LMD) system was used for determining cell-specific miRNAs in rats. Male SD rats (4 weeks old) were purchased from Japan SLC (Shizuoka, Japan). The pancreas was removed and immediately immersed in dry-ice ethanol without any tissueembedding medium and stored at −80°C. Tissue samples were sliced in 6-μm sections and mounted on polyethylene naphthalate membrane slides for microdissection on a cryostat at −20°C. Slides were fixed by immersion in 95% ethanol for 30 s. Cresyl violet and eosin-Y solutions were mixed and directly applied to the sections. The sections were incubated for 20-30 s, which was followed by rinsing in 95% ethanol in 2 steps (1 min each), dehydration in 100% ethanol in 2 steps (1 min each), and removal of the alcohol with xylene in 2 steps (9 min each). Langerhans' islet and acinar cells were divided from the sections by LMD (Leica LMD 7000; Leica Microsystems, Germany). Divided samples were collected into 1.05× denaturing solution from the mirVana PARIS Kit (Ambion, TX, USA), mounted onto the collection device, and purified according to the manufacturer's protocol (13, 18, 24) . miRNA array analysis. Expression profiling of 667 human miRNAs was performed using the ABI TaqMan Human MicroRNA Array kit (Card A and B; Applied Biosystems, CA, USA), according to the manufacturer's instructions, without pre-amplification. U6 small nuclear RNA was included in the TaqMan Human MicroRNA Array and was used as an endogenous control. The ABI Prism 7900 HT Sequence Detection System (Applied Biosystems) was used for amplification and detection. C P values were obtained from the amplification plot using the SDS software (Applied Biosystems), as described previously (13, 18, 24) . Since C P values of > 35 were considered to be below the detection level of the assay, only miRNAs with a C P of ≤ 35 were included in the analyses. There are some limitations in miRNA expression analysis. Since the reliability of this miRNA array system has been reported to be low (18) , the miRNA array system should be used as a tool for screening amount of miR-375 was detected in various tissues in the rat, including salivary gland (Fig. 3 C) . The reliability of the individual assay kits for candidate biomarkers, i.e., miR-216a, miR-216b, and miR-375, was confirmed by using known amounts of synthetic miRNA beforehand (Fig. 2 D-F) . The pancreas is comprised of Langerhans' islets, acinar cells and duct cells. LMD analysis in the rat pancreas indicated that miR-216a and miR-216b were relatively abundantly expressed in acinar cells (Fig. 4 A, B) . miR-375 has been reported to be almost exclusively expressed in beta cells (14) , and our LMD analysis confirmed that miR-375 expression was higher in Langerhans' islets than in acinar cells (Fig. 4 C) . Intriguingly, miR-375 expression appeared to be very high in the pituitary gland, and may not be a specific biomarker for islet injury, which was previously advocated (14) .
Assessment of plasma miRNAs as biomarkers in a rat model of acute pancreatitis
To confirm the usefulness of identification of cellor tissue-specific miRNA, we assessed whether plasma concentrations of miR-216a and miR-216b could be used as biomarkers for pancreatitis. Plasma amylase concentration, a commonly used biomarker for acute pancreatitis, was significantly increased 24 h after L-arginine injection (Fig. 5 A) . Light micrographs of the pancreas showed inflammatory infiltrates and interstitial edema enlargement derived from necrosis of acinar cells (Fig. 6) . Plasma expression levels of miR-216a, miR-216b, and miR-375 were undetectable at baseline and were significantly elevated 24 h after injection of L-arginine. Especially, miR-216a and miR-216b responded sharply than amylase and miR-375, and increased from 12 h after L-arginine administration (Fig. 5 B and C) .
DISCUSSION
According to the results of a keyword search using "miRNA" and "biomarker" on PubMed (http://www. ncbi.nlm.nih.gov/pubmed), the number of papers published in this area is increasing every year and total amount is 2428 in May 2013. Four major applications of miRNA profiling for biomarkers appear to be investigated: diagnosis of cell death based on circulating cell-free cell-specific miRNAs; diagnosis of various diseases based on circulating miRNAs in the exosome; evaluation of the cellular status by miRNA expression profiling, including cancer diagnosis and drug sensitivity; and evaluation of the cellular identity by miRNA expression profiling that
The present study was conducted in accordance with the guidelines of the National Cerebral and Cardiovascular Center for the Care and Use of Experimental Animals and the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Adequate measures were taken to minimize the animals' pain and discomfort.
Statistical Analysis. Data are presented as mean ± SD. Statistical analysis was performed by analysis of variance (ANOVA), regression analysis, and contingency table analysis using the JMP statistical analysis package (SAS Institute, NC, USA).
RESULTS

Tissue-specific miRNAs in human RNAs
In order to identify tissue-specific miRNAs, a total of 667 miRNAs were analyzed in various human tissues, i.e., the brain, cerebellum, lung, adrenal gland, kidney, placenta, liver, heart, uterus, testis, trachea, prostate, colon, thyroid, skeletal muscle, salivary gland, spleen, and pancreas (Fig. 1 , raw data will be provided upon request). From the results of the miRNA array analysis, miR-124 and miR-219-2-3p appeared to be almost exclusively expressed in the brain and cerebellum, as previously reported (42) . The expression of miR-449b appeared to be comparatively intense in the lung. In the placenta, several miRNAs, e.g., miR-515-3p, miR-517a, miR517c, miR-518b, miR-526b, and so on, appeared to be almost exclusively expressed (35) . miR-122 appeared to be exclusively expressed in the liver, as previously reported (9, 15, 26) . miR-499-5p was almost exclusively expressed in the heart (1). In the skeletal muscle, the expression of several miRNAs appeared to be very high, including miR-1, miR133a, and miR-133b (5, 16, 36, 44) . miR-216a and miR-216b appeared to be specifically expressed in the pancreas. Since the tissue-specific expression of miR-449b, miR-216a, and miR-216b might be a new observation made in the present study, the expression of these 3 miRNAs was validated with individual, specific miRNA RT-PCR analysis kits. While the specificity of miR-449b in the lung was not confirmed (data not shown), miR-216a and miR-216b were highly and specifically expressed in the human and rat pancreas (Figs. 2 A, B and 3 A, B) . Simultaneously, we examined miR-375, which was already reported as biomarker for pancreas injury (14) . Although miR-375 was detected almost exclusively in the pancreas in human samples (Fig. 2 C) , a certain Various tissue-specific miRNAs were identified, i.e., miR-124 and miR-219-2-3p in the brain and cerebellum, miR449b in the lung, miR-122 in the liver, miR-499-5p in the heart, miR-1 in the skeletal muscle, and miR-216a and miR-216b in the pancreas. In the placenta, the miRNA profile showed a peculiar pattern and many miRNAs were almost exclusively expressed. B: brain, Cr: cerebellum, Lu: lung, AG: adrenal gland, K: kidney, Pl, placenta, Li: liver, H: heart, U: uterus, Te: testis, Tr: trachea, Pr: prostate, Co: colon, TG: thyroid gland, SM: smooth muscle, SG: salivary gland, Sp: spleen, Pa: pancreas might be useful as a differentiation marker for ES and iPS cells. The present result showed that miR216a and miR-216b could be useful biomarkers for pancreatic acinar cell injuries, including acute pancreatitis. Kong et al. reported that circulating plasma miR-216a is as biomarker for acute pancreatic injury of the rat induced by L-arginine administration and may help in distinguishing between pancreatic injury and nonspecific hyperamylasemia (28). Our study not only confirmed Kong's report but also extended the earlier findings, i.e., miR-216b was also a specific marker for pancreatic acinar cells, and specific expression of miR-216a and miR-216b in pancreatic acinar cells was more thoroughly confirmed. Similar to amylase leakage, miR-216a and miR-216b leakage from acinar cells was caused by autolysis. However, the changes in the expressions of miR-216a and miR-216b appeared to be more sensitive than that of amylase, a commonly used biomarker for acute pancreatitis. It is known that miR-375 is highly expressed in Langerhans' islets (39), and Erener et al. reported that circulating miR-375 is a biomarker of beta-cell death and diabetes in mice (14) . Certainly, plasma miR-375 level was increased in acute pancreatitis of present study. However, miR-375 is highly expressed Fig. 2 Validation of tissue-specific microRNAs (miRNAs) in human tissues. The expression levels of miRNAs identified by miRNA array analysis were confirmed by real-time reverse transcription-polymerase chain reaction. As result, miR-216a (A), miR-216b (B), and miR-375 (C) were highly expressed in the pancreas. The reliabilities of the individual assay kit for miR216a (D), miR-216b (E), and miR-375 (F) were assessed by using known amounts of synthetic miRNA.
lation, and duct obstruction (32) . Intraperitoneal injection of a basic amino acid such as L-arginine induces necrosis of acinar cells; the necrotic cells are subsequently replaced by interstitial tissue comprising inflammatory cells and fibroblasts. Administration of caerulein, an ortholog of cholecystokinin, at supraphysiologic concentrations causes a mild and reversible form of pancreatitis. The animal model of pancreatic bile duct ligation represents a model in the pituitary gland and is not a specific marker for injury to Langerhans' islets. Moreover, miR-375 is being intensively studied in the field of head and neck squamous cell carcinoma (21) and breast cancer (25) . Animal models of acute pancreatitis have been created to examine the pathogenesis of this disease. The commonly used models are as follows: basic amino acid-induced pancreatitis, secretagogue hyperstimu- Fig. 3 Validation of tissue-specific microRNAs (miRNAs) in rat tissues. The expression levels of miR-216a, 216b, and 375 in rat tissues were examined by real-time reverse transcription-polymerase chain reaction. As result, miR-216a (A) and miR216b (B) were almost exclusively expressed in the pancreas. However, tissue-specific expression of miR-375 (C) was not confirmed. amylase, in the morbidity that a small number of cell necroses continuously by chronic pancreatitis or the morbidity which receives an obstacle in autoimmunity. In the future, we will assess the potential of miR-216a and miR-216b as biomarkers of chronic pancreatic diseases in human. As demonstrated by the identification of pancreasspecific miRNAs in this report, miRNA profiling is useful because it identifies cell-or tissue-specific miRNAs that can be applied as biomarkers. The present study showed the usefulness of miRNA array screening with subsequent validation using laof biliary acute pancreatitis; the ligation causes atrophy, fibrosis, and degeneration of exocrine pancreatic tissue (33) . These pancreatitis models show autolysis of acinar cells, interstitial edema, and inflammatory infiltration, similar to the model generated by the administration of L-arginine in this research. To show clearly the increase in the level of cell-specific miRNAs in plasma caused by cellular injury, we used the severe pancreatitis model in the present study. However, we were interested in changes in the plasma levels of miR-216a and miR-216b in comparison with changes in the plasma levels of Fig. 5 Assessment of plasma miR-216a, miR-216b, and miR-375 in the acute pancreatitis model. The plasma amylase concentration was measured by using the Fuji DRI-Chem system (A). Plasma miR-216a (B), miR-216b (C) and miR-375 (D) concentrations were determined by real-time reverse transcription-polymerase chain reaction at 0, 12, 24, 48, and 72 h after L-arginine injection (n = 5 in each time point). The columns with bars represent the mean ± SD. *P < 0.001, **P < 0.05. The plasma amylase concentration was significantly increased 24 h after L-arginine injection. On the other hand, plasma expression levels of miR-216a, miR-216b and miR-375 were undetectable at baseline and were significantly elevated 24 h after injection of L-arginine. miR-216a and miR-216b were increased from 12 h after L-arginine administration. The levels of these miRNAs returned to baseline within 48 h after administration.
for the help in managing the laser microdissection system.
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